What is RPAY's health score?

Repay Holdings Corp (RPAY) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RPAY's estimated fair value?

Based on our 5-year discounted cash flow model, Repay Holdings Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is RPAY undervalued or overvalued?

Our model currently rates RPAY as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RPAY... Refresh in a moment for the full analysis.

Repay Holdings Corp (RPAY)

Technology Overvalued low weak

$3.72

Updated: 2026-06-05

TradeApes Score

Financial Strength

5 Stressed

Operating Trend

65 Healthy

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

70 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.